383 related articles for article (PubMed ID: 16126231)
1. Molecular modeling of blood-brain barrier nutrient transporters: in silico basis for evaluation of potential drug delivery to the central nervous system.
Allen DD; Geldenhuys WJ
Life Sci; 2006 Feb; 78(10):1029-33. PubMed ID: 16126231
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR study of bis-azaaromatic quaternary ammonium analogs at the blood-brain barrier choline transporter.
Geldenhuys WJ; Lockman PR; Nguyen TH; Van der Schyf CJ; Crooks PA; Dwoskin LP; Allen DD
Bioorg Med Chem; 2005 Jul; 13(13):4253-61. PubMed ID: 15878282
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.
Geldenhuys WJ; Lockman PR; McAfee JH; Fitzpatrick KT; Van der Schyf CJ; Allen DD
Bioorg Med Chem Lett; 2004 Jun; 14(12):3085-92. PubMed ID: 15149650
[TBL] [Abstract][Full Text] [Related]
4. Brain drug targeting: a computational approach for overcoming blood-brain barrier.
Mehdipour AR; Hamidi M
Drug Discov Today; 2009 Nov; 14(21-22):1030-6. PubMed ID: 19647097
[TBL] [Abstract][Full Text] [Related]
5. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases.
Löscher W; Potschka H
Prog Neurobiol; 2005 May; 76(1):22-76. PubMed ID: 16011870
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
Pardridge WM
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
[TBL] [Abstract][Full Text] [Related]
7. Carrier-mediated delivery of metabotrophic glutamate receptor ligands to the central nervous system: structural tolerance and potential of the L-system amino acid transporter at the blood-brain barrier.
Reichel A; Begley DJ; Abbott NJ
J Cereb Blood Flow Metab; 2000 Jan; 20(1):168-74. PubMed ID: 10616805
[TBL] [Abstract][Full Text] [Related]
8. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations.
Lee G; Dallas S; Hong M; Bendayan R
Pharmacol Rev; 2001 Dec; 53(4):569-96. PubMed ID: 11734619
[TBL] [Abstract][Full Text] [Related]
9. Macromolecular drug transport into the brain using targeted therapy.
Lichota J; Skjørringe T; Thomsen LB; Moos T
J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
[TBL] [Abstract][Full Text] [Related]
10. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
[TBL] [Abstract][Full Text] [Related]
11. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
Gaillard PJ; de Boer AG
Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
[TBL] [Abstract][Full Text] [Related]
12. 3D QSAR investigation of the blood-brain barrier penetration of chemical compounds.
Lessigiarska I; Pajeva I; Cronin MT; Worth AP
SAR QSAR Environ Res; 2005; 16(1-2):79-91. PubMed ID: 15844444
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery and in vitro models of the blood-brain barrier.
Cucullo L; Aumayr B; Rapp E; Janigro D
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):89-99. PubMed ID: 15679176
[TBL] [Abstract][Full Text] [Related]
14. Constructing optimum blood brain barrier QSAR models using a combination of 4D-molecular similarity measures and cluster analysis.
Pan D; Iyer M; Liu J; Li Y; Hopfinger AJ
J Chem Inf Comput Sci; 2004; 44(6):2083-98. PubMed ID: 15554679
[TBL] [Abstract][Full Text] [Related]
15. Delivery of peptides to the brain: emphasis on therapeutic development.
Banks WA
Biopolymers; 2008; 90(5):589-94. PubMed ID: 18335425
[TBL] [Abstract][Full Text] [Related]
16. 3-D-QSAR and docking studies on the neuronal choline transporter.
Geldenhuys WJ; Allen DD; Lockman PR
Bioorg Med Chem Lett; 2010 Aug; 20(16):4870-7. PubMed ID: 20637607
[TBL] [Abstract][Full Text] [Related]
17. [The blood-brain barrier and drug delivery in the central nervous system].
Loch-Neckel G; Koepp J
Rev Neurol; 2010 Aug; 51(3):165-74. PubMed ID: 20645267
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier delivery.
Pardridge WM
Drug Discov Today; 2007 Jan; 12(1-2):54-61. PubMed ID: 17198973
[TBL] [Abstract][Full Text] [Related]
19. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
Juillerat-Jeanneret L
Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
[TBL] [Abstract][Full Text] [Related]
20. Putative proteins involved in manganese transport across the blood-brain barrier.
Fitsanakis VA; Piccola G; Marreilha dos Santos AP; Aschner JL; Aschner M
Hum Exp Toxicol; 2007 Apr; 26(4):295-302. PubMed ID: 17615110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
